Finance

Beta
Lists
SLXN:NASDAQ
Silexion Therapeutics Corp
US$4,96
+2,06%
(+0,100) 1D
US$4,93
-0,60% (-0,030)
After hours
Closed: 4 ມິ.ຖ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SLXN...
Open
US$4,76
High
US$5,01
Low
US$4,52
Mkt. cap
໒,໐໘ ລ້ານ
Avg. vol.
໑,໒໐ ລ້ານ
Volume
໙໔,໒໗ ພັນ
52-wk high
US$223,60
52-wk low
US$2,31
EPS
US$-94,47
Beta
-໐,໓໑
Shares outstanding
໔໑໙,໐໐ ພັນ
No. of employees
໑໔
Open
US$4,76
High
US$5,01
Low
US$4,52
Mkt. cap
໒,໐໘ ລ້ານ
Avg. vol.
໑,໒໐ ລ້ານ
Volume
໙໔,໒໗ ພັນ
52-wk high
US$223,60
52-wk low
US$2,31
EPS
US$-94,47
Beta
-໐,໓໑
Shares outstanding
໔໑໙,໐໐ ພັນ
No. of employees
໑໔
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to SLXN in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for SLXN in the last 3 months.
Highest
Current US$4,96
US$60,00 (+1.109,68%)
Average
US$60,00 (+1.109,68%)
Lowest
US$60,00 (+1.109,68%)
News stories
From sources across the web
About Silexion Therapeutics Corp
CEO-
Employees14
Founded2008
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
2,16 ລ້ານ
3,38 ລ້ານ
1,37 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
1,14 ລ້ານ
1,03 ລ້ານ
1,38 ລ້ານ
Operating expense
-
3,29 ລ້ານ
4,41 ລ້ານ
2,75 ລ້ານ
Total operating expenses
-
3,29 ລ້ານ
4,41 ລ້ານ
2,75 ລ້ານ
Operating income
-
-3,29 ລ້ານ
-4,41 ລ້ານ
-2,75 ລ້ານ
Other non operating income
-
23,00 ພັນ
-35,00 ພັນ
11,00 ພັນ
EBT including unusual items
-
-3,26 ລ້ານ
-4,41 ລ້ານ
-2,73 ລ້ານ
EBT excluding unusual items
-
-3,26 ລ້ານ
-4,41 ລ້ານ
-2,73 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-3,26 ລ້ານ
-4,41 ລ້ານ
-2,73 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
39,00 ພັນ
69,00 ພັນ
32,00 ພັນ
Interest expense
-
-
-
-
Net interest expenses
-
39,00 ພັນ
69,00 ພັນ
32,00 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-3,29 ລ້ານ
-4,40 ລ້ານ
-2,75 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more